SCHEMBL30888552

SCHEMBL30888552

COc1c(Cl)c(F)c2c(c1C(=O)O)CCCC2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 4/20 0.40
KDM4E B2RXH2 3/20 0.40
ALDH1A1 P00352 3/20 0.40
CYP2C9 P11712 2/20 0.35
MEN1 O00255 7/20 0.33
KMT2A Q03164 7/20 0.33
GFER P55789 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
CYP1A2 P05177 1/20 0.33
GLO1 Q04760 1/20 0.32
HCAR2 Q8TDS4 1/20 0.32
MEP1B Q16820 1/20 0.32
TPMT P51580 1/20 0.31
IMPDH2 P12268 2/20 0.31
TSHR P16473 1/20 0.31
MAPT P10636 3/20 0.30
HPGD P15428 3/20 0.30
ALOX15 P16050 3/20 0.30
THRB P10828 1/20 0.30
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30888672 0.77 CA1 (0.32)
SCHEMBL27480678 0.73 ALDH1A1 (0.47) HSD17B10KDM4EALDH1A1CYP2C9MEN1
SCHEMBL27819507 0.72 PTPN1 (0.44) HSD17B10KDM4EALDH1A1CYP2C9MEN1
SCHEMBL30888657 0.72 METAP2 (0.39) HSD17B10KDM4EALDH1A1CYP2C9MEN1
SCHEMBL6609247 0.71 HPGD (0.40) HSD17B10KDM4EALDH1A1MEN1KMT2A
SCHEMBL30888487 0.71 ALDH1A1 (0.50) HSD17B10KDM4EALDH1A1MEN1KMT2A
SCHEMBL26882460 0.70 KDM4E (0.44) HSD17B10KDM4EALDH1A1CYP2C9MEN1
SCHEMBL30888584 0.70 ALDH1A1 (0.49) HSD17B10KDM4EALDH1A1MEN1KMT2A
SCHEMBL30888597 0.70 ALDH1A1 (0.49) HSD17B10KDM4EALDH1A1MEN1KMT2A
SCHEMBL30888592 0.70 ALDH1A1 (0.49) HSD17B10KDM4EALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4630403-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD Pharma A/S (DK) 2025-10-15 EP disclosed
WO-2024121129-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD PHARMA A/S (DK) 2024-06-13 WO disclosed